COMPREHENSIVE Q and A WITH
DETAILED RATIONALES NRS and NAC
639/453
Nevada MPJE Practice Exam
1. Under Nevada law, a pharmacist must perform a prospective drug
use review (DUR) before dispensing any prescription. Which of the
following is NOT a required component of this review?
A. Screening for therapeutic duplication.
B. Screening for drug-allergy interactions.
C. Checking the patient's current address for insurance billing
accuracy.
D. Screening for clinical abuse or misuse.
C. Checking the patient's current address for insurance
billing accuracy.
Rationale: NAC 639.707 specifies that a DUR must include
therapeutic duplication, drug-disease contraindications, drug-
drug interactions, incorrect dosage/duration, drug-allergy
interactions, and clinical abuse/misuse. Billing accuracy is an
administrative task, not a clinical DUR requirement.
2. What is the maximum number of members on the Nevada State
Board of Pharmacy, and how many must be registered
pharmacists?
A. 5 members; all must be pharmacists.
B. 7 members; 6 must be pharmacists.
C. 7 members; 5 must be pharmacists.
D. 9 members; 7 must be pharmacists.
B. 7 members; 6 must be pharmacists.
Rationale: NRS 639.020 states the Board consists of seven
members appointed by the Governor. Six members must be
registered pharmacists with at least 5 years of experience in
Nevada, and one member represents the general public.
3. In Nevada, a prescription for a Schedule II controlled substance
must be filled within how many days of the date it was issued?
A. 7 days.
, B. 14 days.
C. 30 days.
D. 6 months.
B. 14 days.
Rationale: NRS 453.431 (and related emergency regulations)
strictly limits the validity of a Schedule II prescription to 14 days
from the date of issue in Nevada, which is more restrictive than
federal law.
4. Which of the following is required on a prescription label for a
controlled substance in Nevada but NOT necessarily by federal
law?
A. The date of initial filling.
B. The pharmacy’s phone number.
C. The symptom or purpose for which the drug is prescribed, if
requested by the patient.
D. The DEA number of the prescribing practitioner.
C. The symptom or purpose for which the drug is
prescribed, if requested by the patient.
Rationale: NRS 639.2801 requires that if a patient requests the
"symptom or purpose" be included on the label, the pharmacist
must do so if it is provided on the prescription.
5. A pharmacist in Nevada receives a prescription for a non-
controlled drug that has "PRN" refills. How long is this
prescription valid?
A. 6 months.
B. 1 year.
C. 2 years.
D. Indefinitely.
B. 1 year.
Rationale: Under NAC 639.712, a prescription for a dangerous
drug (non-controlled) is valid for a maximum of 1 year from the
date of issue, regardless of the number of refills authorized.
6. What is the minimum number of hours of Continuing Education
(CE) required for a Nevada pharmacist to renew their license
biennially?
A. 15 hours.
B. 20 hours.
C. 30 hours.
D. 40 hours.
, C. 30 hours.
Rationale: NAC 639.190 requires 30 hours of CE per biennial
period. At least 15 of these hours must be in accredited programs,
and 1 hour must be in Nevada pharmacy law.
7. Under Nevada law, which person is authorized to access the
Prescription Monitoring Program (PMP) database without a
specific criminal investigation?
A. A pharmaceutical sales representative.
B. A practitioner providing medical evaluation or treatment to a
patient.
C. An employer checking a potential employee's history.
D. A patient’s spouse.
B. A practitioner providing medical evaluation or
treatment to a patient.
Rationale: NRS 453.1645 allows practitioners and pharmacists to
access PMP data to provide medical or pharmaceutical care.
Unauthorized access for employment or personal reasons is
prohibited.
8. When a pharmacy technician in Nevada performs tasks related to
the preparation of prescriptions, what is the maximum ratio of
technicians to pharmacists in a community pharmacy setting?
A. 1:1
B. 2:1
C. 3:1
D. 4:1
C. 3:1
Rationale: NAC 639.250 states that a pharmacist may not
supervise more than three pharmacy technicians at one time,
though certain exceptions exist for hospital or mail-order settings
with specific Board approval.
9. A Nevada pharmacist may dispense a 90-day supply of a drug
(other than a controlled substance) even if the prescription is
written for a 30-day supply with refills, provided that:
A. The patient has already used an initial 30-day supply.
B. The total quantity does not exceed the total refills authorized.
C. The prescriber has not indicated "Dispense as Written."
D. All of the above.
D. All of the above.
Rationale: NRS 639.2396 allows pharmacists to combine refills
, for up to a 90-day supply for non-controlled substances if the
patient has used an initial 30-day supply and the prescriber
hasn't prohibited it.
10. If a pharmacy in Nevada experiences a significant loss of
controlled substances, within what timeframe must they notify the
Board of Pharmacy?
A. Immediately.
B. Within 24 hours.
C. Within 10 days.
D. Within 30 days.
C. Within 10 days.
Rationale: While federal law (DEA) requires notification within
one business day, NAC 639.480 requires a written report to the
Nevada Board within 10 days of discovery.
11. Which of the following is true regarding the "initial prescription"
for an opioid for acute pain in Nevada?
A. It cannot exceed a 3-day supply.
B. It cannot exceed a 7-day supply.
C. It cannot exceed a 14-day supply.
D. There is no day supply limit, only a dosage limit.
B. It cannot exceed a 7-day supply.
Rationale: Under NRS 639.2391, a practitioner shall not issue an initial
prescription of a controlled substance listed in schedule II, III, or IV for
the treatment of acute pain that exceeds a 7-day supply.
12. According to Nevada law, how often must a pharmacy conduct a
physical inventory of all controlled substances?
A. Every year.
B. Every 2 years.
C. Every 3 years.
D. Every 5 years.
B. Every 2 years.
Rationale: NRS 453.246 and federal law require a biennial inventory
(every 2 years) of all controlled substances on hand.
13. A Nevada pharmacist receives an oral prescription for a Schedule
II controlled substance in an emergency. Within what timeframe must
the prescriber provide a written "covering" prescription?
A. 48 hours.
B. 72 hours.